CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Open-market sale Chief Patient Supply Officer sold 2,939 shares at $3.58 ($10,536)
- 4 Open-market sale Chief Operating Officer sold 4,375 shares at $4.26 ($18,659)
- 4 Open-market sale Chief Patient Supply Officer sold 1,907 shares at $4.26 ($8,133)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 2,794 shares at $4.37 ($12,210)
- 4 Open-market buy Director bought 12,600 shares at $0.79 ($9,954)
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Option exercise Chief Business Officer acquired 1,785,000 shares (option exercise)
Page 16 of 41 · 808 filings